Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Sales: 2021-2025

Historic Return on Sales for Allogene Therapeutics (ALLO) over the last 2 years, with Sep 2025 value amounting to 248.62%.

  • Allogene Therapeutics' Return on Sales was N/A to 248.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 248.62%, marking a year-over-year change of. This contributed to the annual value of -2.25% for FY2021, which is N/A change from last year.
  • Per Allogene Therapeutics' latest filing, its Return on Sales stood at 248.62% for Q3 2025, which was down 36.20% from 389.71% recorded in Q2 2025.
  • Over the past 5 years, Allogene Therapeutics' Return on Sales peaked at 805.76% during Q1 2025, and registered a low of -3.11% during Q3 2022.
  • For the 1-year period, Allogene Therapeutics' Return on Sales averaged around 481.37%, with its median value being 389.71% (2025).